Tissue microarray technology: principles, pitfalls and perspectives—lessons learned from hematological malignancies
Authors:
- Alexandar TzankovATAlexandar Tzankov
- Philip WentPWPhilip Went
- Annette ZimpferAZAnnette Zimpfer
- Stephan DirnhoferSDStephan Dirnhofer
- 1 August 2005
- journal article
- research article
- Published by Elsevier in Experimental Gerontology
- Vol. 40 (8-9) , 737-744
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Expression of the bcl‐6 and MUM1/IRF4 proteins correlate with overall and disease‐specific survival in patients with primary cutaneous large B‐cell lymphoma: a tissue microarray studyJournal of Cutaneous Pathology, 2005
- Aberrant expression of cell cycle regulators in Hodgkin and Reed–Sternberg cells of classical Hodgkin's lymphomaLaboratory Investigation, 2005
- Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphomaLaboratory Investigation, 2004
- Rare expression of KIT (CD117) in lymphomas: a tissue microarray study of 1166 casesHistopathology, 2004
- Expressionsmuster und prognostische Bedeutung von CD24, p53 und p21 in LymphomenDMW - Deutsche Medizinische Wochenschrift, 2004
- Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 casesJournal of Clinical Pathology, 2003
- High‐throughput tissue microarray analysis of G1‐cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1The Journal of Pathology, 2003
- Apoptotic Rate in Peripheral T-Cell LymphomasAmerican Journal of Clinical Pathology, 2002
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998